Turn Therapeutics Inc. (TTRX) Stock Analysis & Investment Frameworks
Turn Therapeutics Inc. (TTRX) stock analysis on Invetso. Review Turn Therapeutics Inc.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
Turn Therapeutics Inc. Company Overview
- Exchange: NASDAQ Global Select
- Sector: Healthcare
- Industry: Biotechnology
- Country: US
Turn Therapeutics Inc. Key Financial Metrics
- Market Cap: $314.86M
- Revenue: $N/A
- ROE: -280.41%
- ROIC: -84.66%
- Dividend Yield: N/A
About Turn Therapeutics Inc.
Turn Therapeutics Inc., officially known as Global Health Solutions, Inc., is a pharmaceutical enterprise dedicated to developing treatments for conditions affecting the skin, nails, and eyes. The company utilizes a proprietary drug delivery system engineered to effectively permeate skin and nail tissues. This advanced technology is integrated into their solutions for both acute and chronic wound care, specifically designed to help combat antibiotic resistance. Consequently, these products empower healthcare institutions to effectively manage a broad spectrum of dermatological challenges, encompassing everything from sudden injuries and persistent wounds to general skin ailments and specific dermatoses. Global Health Solutions, Inc. was established in 2015 and maintains its headquarters in Westlake Village, California.
Turn Therapeutics Inc. Investment Frameworks
Invetso analyzes Turn Therapeutics Inc. (TTRX) across the following frameworks:
- Turn Therapeutics Inc. 10Y Growth Potential
- Turn Therapeutics Inc. Scenario Analysis
- Turn Therapeutics Inc. Risks & Opportunities
- Turn Therapeutics Inc. Economic Moat
- Turn Therapeutics Inc. Business Model
- Turn Therapeutics Inc. Management
- Turn Therapeutics Inc. SWOT Analysis
- Turn Therapeutics Inc. Porter's 5 Forces
- Turn Therapeutics Inc. PESTLE Analysis
- Turn Therapeutics Inc. ESG Analysis